Palo Alto, CA — July 7, 2016 — Theranos today announced it received notice from the Centers for Medicare & Medicaid Services (CMS) regarding the imposition of sanctions arising from the 2015 survey of its Newark, California laboratory.

The sanctions, which do not immediately take effect, include:

– Revocation of the laboratory’s CLIA certificate which, as dictated by the regulations, includes a prohibition on owners and operators of the lab from owning, operating or directing a lab for at least two years from the date of revocation
– Limitation of the laboratory’s CLIA certificate for the specialty of hematology
– A Civil Money Penalty
– A Directed Portion of a Plan of Correction
– Suspension of the laboratory’s approval to receive Medicare and Medicaid payments for any services performed for the specialty of hematology
– Cancellation of the laboratory’s approval to receive Medicare and Medicaid payments for all laboratory services

“We accept full responsibility for the issues at our laboratory in Newark, California, and have already worked to undertake comprehensive remedial actions. Those actions include shutting down and subsequently rebuilding the Newark lab from the ground up, rebuilding quality systems, adding highly experienced leadership, personnel and experts, and implementing enhanced quality and training procedures,” said Elizabeth Holmes, Theranos founder and CEO. “While we are disappointed by CMS’ decision, we take these matters very seriously and are committed to fully resolving all outstanding issues with CMS and to demonstrating our dedication to the highest standards of quality and compliance.”

While the revocation would not take effect for 60 days, the company will not conduct any patient testing in the Newark lab until further notice. During this period, the company will continue to work with CMS to resolve and remediate outstanding issues in the Newark lab, and will continue to provide services to its customers through its Arizona lab.

About Theranos
Theranos, Inc. is a consumer health technology company founded in 2003 by Elizabeth Holmes. Theranos’ mission is to make actionable information accessible to everyone at the time it matters most. By doing so, Theranos is working to facilitate the early detection and prevention of disease and to empower people everywhere to live their best lives. Theranos offers lab tests in convenient locations in its Wellness Centers in Arizona and California.

Media Contact:
Theranos Public Relations
pr@theranos.com